Cargando…
国产阿扎胞苷治疗较高危骨髓增生异常综合征患者的疗效和安全性分析:多中心、前瞻性、单臂研究
OBJECTIVE: To evaluate the efficacy, safety, and pharmacokinetics of the generic azacitidine in Chinese patients with higher-risk myelodysplastic syndromes(MDS). METHODS: Between October 2013 and 2016, 72 patients were eligible for enrollment at 9 sites from China received generic subcutaneous azaci...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656073/ https://www.ncbi.nlm.nih.gov/pubmed/33190437 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.10.004 |
Ejemplares similares
-
维奈克拉联合阿扎胞苷治疗急性髓系白血病的近期疗效:单中心数据
Publicado: (2022) -
单中心阿扎胞苷联合维奈克拉和联合HAG方案诱导治疗老年急性髓系白血病的疗效比较
Publicado: (2023) -
维奈克拉联合阿扎胞苷治疗难治复发性急性髓系白血病疗效及安全性分析
Publicado: (2021) -
维奈克拉联合阿扎胞苷治疗不适合标准化疗的新诊断急性髓系白血病疗效分析:单中心数据
Publicado: (2022) -
阿扎胞苷联合HA方案在急性髓系白血病诱导及挽救治疗中的疗效分析
Publicado: (2022)